Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008411 |
ID: | TCMBANKHE008411 |
植物拉丁名: |
|
功能与主治: | To disperse accumulation, expel roundworm./Food accumulation, ascariasis. |
药用植物名: | 美丽红豆杉 |
药用部位: | seed |
TCM_ID_id: | 6634 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000027 | taxol | Paclitaxel | C47H51NO14 | 853.91 | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C |
| TCMBANKIN000735 | takatonine | C21H24NO4+ | C[N+]1=C(C2=C(C(=C(C=C2C=C1)OC)OC)OC)CC3=CC=C(C=C3)OC | ||
| TCMBANKIN000927 | taxinine b | C37H44O11 | 664.7 g/mol | CC1=C2C(C(C3(C(CC(C(=C)C3C(C(C2(C)C)CC1=O)OC(=O)C)OC(=O)C=CC4=CC=CC=C4)OC(=O)C)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN000933 | 7-Deacetylcanadensene | [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetoxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] acetate; [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetyloxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] ethanoate; acetic acid [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetoxy-5,7-dihydroxy-8,12,15,15-tetramethyl-4-methylol-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] ester; acetic acid [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetoxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] ester; 7-deacetylcanadensene; [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetyloxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] acetate | C28H40O11 | 552.61 | CC1=C(C(C2=C(C(CC(C2(C)C)C(C=C(C(CC1O)O)CO)OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C |
| TCMBANKIN001436 | taxumairol d | C30H42O13 | 610.6 g/mol | CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)OC(=O)C)C)OC(=O)C)O | |
| TCMBANKIN001718 | 13-o-deacetyltaxumairolz | C31H40O12 | 604.6 g/mol | CC1=C2C(C(C3(C(CC4C(C3C(C2(CC1O)C(C)(C)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)COC(=O)C)O)O | |
| TCMBANKIN003308 | taiwanxan | C31H46O9 | CCC(C)C(=O)OC1CC(=C2C(C(C3(CCC(C(=C)C3C(C1C2(C)C)OC(=O)C)O)C)OC(=O)C)OC(=O)C)C | ||
| TCMBANKIN004242 | 2-α- furan ethanol | ||||
| TCMBANKIN005152 | 19-hydroxybaccatin iii | C31H38O12 | 602.6 g/mol | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)CO)OC(=O)C | |
| TCMBANKIN007522 | yunnanxol | C40H46O14 | 750.8 g/mol | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)O)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)OC(=O)C | |
| TCMBANKIN008433 | taxinine e | C37H46O10 | 650.8 g/mol | CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C)OC(=O)C=CC4=CC=CC=C4)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN009253 | taxumairolz | C33H42O13 | 646.7 g/mol | CC1=C2C(C(C3(C(CC4C(C3C(C2(CC1OC(=O)C)C(C)(C)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)COC(=O)C)O)O | |
| TCMBANKIN012709 | 13-deacetylcanadensene | C28H40O11 | CC1=C2C(C(=C(C(CC(C(=CC(C(C2(C)C)CC1O)OC(=O)C)CO)O)OC(=O)C)C)OC(=O)C)OC(=O)C | ||
| TCMBANKIN014789 | taxumairol b | C28H40O12 | 568.6 g/mol | CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)O)OC(=O)C | |
| TCMBANKIN015760 | yunnanxane | C31H46O9 | 562.7 g/mol | CC1=C2C(CC3(CCC(C(=C)C3C(C(C2(C)C)C(C1)OC(=O)C(C)C(C)O)OC(=O)C)OC(=O)C)C)OC(=O)C | |
| TCMBANKIN016612 | 1beta-hydroxybaccatin i | 1β-hydroxybaccatin i | C32H44O14 | 652.7 g/mol | CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C |
| TCMBANKIN017924 | 9α-hydroxy-14β-(2-methylbutyryl)-oxy-2α,5α,10β-tri acetoxytaxa-4(20),11-diene | 9alpha-hydroxy-14beta-(2-methylbutyryl)oxy-2alpha,5alpha,10beta-triacetoxytaxa-4(20),11-diene | C31H46O9 | ||
| TCMBANKIN022404 | taxinine j | C39H48O12 | 708.8 g/mol | CC1=C2C(C(C3(C(CC(C(=C)C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C)OC(=O)C=CC4=CC=CC=C4)OC(=O)C)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN023546 | 1-hydroxy-2,7,9-trideacetylbaccatin i | C26H38O11 | CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)O)CO4)OC(=O)C)O)C)O)OC(=O)C | ||
| TCMBANKIN023804 | taxumairol c | C26H38O11 | 526.6 g/mol | CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)O)O | |
| TCMBANKIN023913 | taxusin | C28H40O8 | 504.6 g/mol | CC1=C2C(C(C3(CCC(C(=C)C3CC(C2(C)C)CC1OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN026958 | 9alpha,10beta-diacetoxy-5alpha,13alpha-dihydroxy-4(20),11-taxadiene | 9α,10β-diacetoxy-5α,13α-dihydroxy-4(20),11-taxadiene | C24H36O6 | CC1=C2C(C(C3(CCC(C(=C)C3CC(C2(C)C)CC1O)O)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN028127 | 2α-(α-methylbutyryl)-oxy-5α,7β,9α,10β-tetra-acetoxy-4(20),11-taxadiene | C33H48O10 | |||
| TCMBANKIN030062 | taxinine a | C26H36O8 | 476.6 g/mol | CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)CC1=O)OC(=O)C)O)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN032444 | taxinine k | C26H36O8 | CC1C(=O)CC2C(C34C1(C2(C)C)C(C(C3(CCC(C4=C)O)C)OC(=O)C)OC(=O)C)OC(=O)C | ||
| TCMBANKIN033682 | 5alpha-cinnamoyloxy-9alpha,10beta,13alpha-triacetoxytaxa-4(20),11-diene | 5α-cinnamoyloxy-9α,10β,13α-triacetoxytaxa-4(20),11-diene | C35H44O8 | ||
| TCMBANKIN034372 | taxinine | C35H42O9 | 606.7 g/mol | CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)CC1=O)OC(=O)C)OC(=O)C=CC4=CC=CC=C4)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN036974 | 1beta-dehydroxybaccatin iv | 1β-dehydroxybaccatin iv | C32H44O13 | CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C)(CO4)OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN037455 | dehydroxy-15-o-methtylcimigenol | C31H48O4 | |||
| TCMBANKIN037749 | Taxumairol U | 612.7 g/mol | |||
| TCMBANKIN038179 | 2alpha,5alpha,9alpha-trihydroxy-10beta,13alpha-diacetoxy-4beta,20-epoxytaxa-11-ene | 2α,5α,9α-trihydroxy-10β,13α-diacetoxy-4β,20-epoxytaxa-11-ene | C24H36O8 | CC1=C2C(C(C3(CCC(C4(C3C(C(C2(C)C)CC1OC(=O)C)O)CO4)O)C)O)OC(=O)C | |
| TCMBANKIN038454 | Taxumairol F | C30H42O13 | 610.6 g/mol | C1(=C(C([H])([H])[H])[C@@]([H])(O[H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]2(O[H])[C@]([H])(OC(=O)C([H])([H])[H])[C@]([H])([C@@]3(OC3([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])C([H])([H])[C@]4 ([H])OC(=O)C([H])([H])[H])[C@]4(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])[C@]1([H])OC(=O)C([H])([H])[H] | |
| TCMBANKIN038675 | taxinine h | C28H38O9 | CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)CC1=O)OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C | ||
| TCMBANKIN038942 | Hydroxytriacetoxytaxadiene | ||||
| TCMBANKIN039058 | 1beta-dehydroxy-4alpha-deacetylbaccatin iv | 1β-dehydroxy-4α-deacetylbaccatin iv | C30H42O12 | CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C)(CO4)O)OC(=O)C)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN040384 | taxumairol w | C28H40O12 | CC1=C2C(C(C3(C(CC4C(C3C(C2(CC1O)C(C)(C)O)OC(=O)C)(CO4)OC(=O)C)OC(=O)C)C)O)OC(=O)C | ||
| TCMBANKIN040473 | taxumairol h | C33H42O12 | 630.7 g/mol | CC1=C(CC2(C1C(C(C3(C(CC(C4(C3C2OC4)O)O)OC(=O)C)C)OC(=O)C)OC(=O)C)C(C)(C)OC(=O)C5=CC=CC=C5)O | |
| TCMBANKIN040866 | 7β,13α-diacetoxy-2α,5α,10β-trihydroxy-2(3→20)abeotaxane-9-one | C24H34O8 | |||
| TCMBANKIN040885 | Baccatin III 13-cinnamate | ||||
| TCMBANKIN040894 | 1beta-dehydroxybaccatin vi | 1β-dehydroxybaccatin vi | C37H46O13 | 698.8 g/mol | CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C |
| TCMBANKIN041139 | Taxumain A | C30H44O13 | 612.7 g/mol | [C@@]1([H])(O[H])[C@]([H])(OC(=O)C([H])([H])[H])[C@](C([H])([H])[H])([C@@]([H])(OC(=O)C([H])([H])[H])C([H])([H])[C@]([H])(OC(=O)C([H])([H])[H])[C@]2(C([H])([H])OC(C([H])([H])[H])=O)[H])[C@]2([H])[C@]( [H])(OC(=O)C([H])([H])[H])[C@@]3(C(C([H])([H])[H])(O[H])C([H])([H])[H])C1=C(C([H])([H])[H])[C@@]([H])(O[H])C3([H])[H] | |
| TCMBANKIN041254 | 2-hydroxy-3-o-tigloylswietenolide | C32H40O10 | CC=C(C)C(=O)OC1C(C(C2(C3CCC4(C(OC(=O)CC4=C3CC1(C2=O)O)C5=COC=C5)C)C)C(C(=O)OC)O)(C)C | ||
| TCMBANKIN041548 | taxumairol x | C24H36O10 | 484.5 g/mol | CC1=C2C(C(C3(C(CC(C4(C3C(C2(CC1O)C(C)(C)O)OC4)O)O)OC(=O)C)C)OC(=O)C)O | |
| TCMBANKIN041557 | 5alpha-(Cinnamoyl)oxy-7beta-hydroxy-9alpha,10beta,13alpha-triacetoxytaxa-4(20),11-diene | C35H44O9 | C1(=C([C@@]([H])(OC(=O)C([H])([H])[H])C2([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]2([H])C([H])([H])[C@]([H])(C(=C([H])[H])[C@@]([H])(OC(\C([H])=C([H])/c3c([H])c([H])c([H])c([H])c3[H ])=O)C([H])([H])[C@]4([H])O[H])[C@]4(C([H])([H])[H])[C@@]([H])(OC(C([H])([H])[H])=O)[C@]1([H])OC(=O)C([H])([H])[H] | ||
| TCMBANKIN041694 | taxumairol l | C32H46O14 | 654.7 g/mol | CC1=C2C(C(C3(C(CC(C(C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C)(COC(=O)C)O)O)OC(=O)C)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN042021 | 2alpha,7beta-dibenzoyl-5beta,20-epoxy-1beta-hydroxy-4alpha,9alpha,10beta,13alpha-tetraacetoxytax-11-ene | 2α,7β-dibenzoyl-5β,20-epoxy-1β-hydroxy-4α,9α,10β,13α-tetraacetoxytax-11-ene | C42H48O14 | ||
| TCMBANKIN042739 | deacetoxyvinblastine | C43H54N4O7 | CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(CC(C8N6)(C(=O)OC)O)(C=CC9)CC)OC)C(=O)OC)O | ||
| TCMBANKIN043070 | Taxumairol E | C30H44O12 | 596.7 g/mol | C1(=C(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]2([H])[C@@]([H])(O[H])[C@]([H])([C@]([H])(C([H])([H])O[H])[C@@]([H])(OC(=O)C([H])([H])[H])C([H])([H ])[C@]3([H])OC(=O)C([H])([H])[H])[C@]3(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])[C@]1([H])OC(=O)C([H])([H])[H] | |
| TCMBANKIN043388 | Taxumairol J | 508.6 g/mol | |||
| TCMBANKIN043415 | 3,5-Diacetyltambulin | 428.4 g/mol | |||
| TCMBANKIN043492 | 14beta-hydroxytaxusin | 14β-hydroxytaxusin | C28H40O9 | 520.6 g/mol | CC1=C2C(C(C3(CCC(C(=C)C3CC(C2(C)C)C(C1OC(=O)C)O)OC(=O)C)C)OC(=O)C)OC(=O)C |
| TCMBANKIN043978 | Taxuspinanane A | C47H59NO14 | 862 g/mol | C1(=C(C([H])([H])[H])[C@@]([H])(OC(=O)[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)C([H])([H])C([H])([H])[C@]([H])(C([H])([H])C([H])([H])[H])C([H])([H])[H])c2c([H])c([H])c([H])c([H])c2[H])C3([H])[H])C(C([H])( [H])[H])(C([H])([H])[H])[C@]3(O[H])[C@]([H])(OC(=O)c4c([H])c([H])c([H])c([H])c4[H])[C@]([H])([C@@]5(OC(=O)C([H])([H])[H])[C@@]([H])(OC5([H])[H])C([H])([H])[C@@]6([H])O[H])[C@]6(C([H])([H])[H])C(=O)[C@ ]1([H])OC(C([H])([H])[H])=O | |
| TCMBANKIN044051 | 5alpha-Cinnamoyloxy-2alpha,13alpha-dihydroxy-9alpha,10beta-diacetoxy-4(20),11-taxadiene | 5α-cinnamoyloxy-2α,13α-dihydroxy-9α,10β-diacetoxy-4(20),11-taxadiene | C33H42O8 | C1(=C([C@@]([H])(O[H])C2([H])[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]2([H])[C@@]([H])(O[H])[C@]([H])(C(=C([H])[H])[C@@]([H])(OC(\C([H])=C([H])/c3c([H])c([H])c([H])c([H])c3[H])=O)C([H]) ([H])C4([H])[H])[C@]4(C([H])([H])[H])[C@@]([H])(OC(C([H])([H])[H])=O)[C@]1([H])OC(=O)C([H])([H])[H] | |
| TCMBANKIN044256 | taxamedin a | C37H46O11 | CC1=C2C(C(C3(CCC(C(=C)C3C(C2(CC1OC(=O)C)C(C)(C)O)OC(=O)C)OC(=O)C=CC4=CC=CC=C4)C)OC(=O)C)OC(=O)C | ||
| TCMBANKIN044763 | Taxumain B | C32H46O14 | 654.7 g/mol | [C@@]1([H])(O[H])[C@]([H])(OC(=O)C([H])([H])[H])[C@](C([H])([H])[H])([C@@]([H])(OC(=O)C([H])([H])[H])C([H])([H])[C@]([H])(OC(=O)C([H])([H])[H])[C@]2(C([H])([H])OC(C([H])([H])[H])=O)[H])[C@]2([H])[C@]( [H])(OC(=O)C([H])([H])[H])[C@@]3(C(C([H])([H])[H])(O[H])C([H])([H])[H])C1=C(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])C3([H])[H] | |
| TCMBANKIN045414 | taxumairol g | C37H46O14 | 714.8 g/mol | CC1=C(CC2(C1C(C(C3(C(CC(C4(C3C2OC4)OC(=O)C)O)OC(=O)C)C)OC(=O)C)OC(=O)C)C(C)(C)OC(=O)C5=CC=CC=C5)OC(=O)C | |
| TCMBANKIN046143 | Taxumairol V | 570.6 g/mol | |||
| TCMBANKIN046384 | Taxumairol I | 550.6 g/mol | |||
| TCMBANKIN047175 | Taxamairin B | C22H24O4 | 352.424 | C1(=O)C(C([H])([H])[H])(C([H])([H])[H])C(=C2[H])C(=C([H])c(c(OC([H])([H])[H])c(OC([H])([H])[H])c(C([H])(C([H])([H])[H])C([H])([H])[H])c3[H])c3C2=O)C([H])=C1[H] | |
| TCMBANKIN047271 | 2-Deacetyl-10-acetyltaxine B | ||||
| TCMBANKIN047904 | taxumairol y | C26H38O11 | 526.6 g/mol | CC1=C2C(C(C3(C(CC(C4(C3C(C2(CC1OC(=O)C)C(C)(C)O)OC4)O)O)OC(=O)C)C)OC(=O)C)O | |
| TCMBANKIN048387 | alpha-Methyl-n-butyrylshijonin | C20H22O6 | 358.385 | c1([H])c(O[H])c(C(=O)C([H])=C([C@](OC(=O)[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C2=O)c2c(O[H])c1[H] | |
| TCMBANKIN048454 | Taxamairin A | C21H22O4 | 338.397 | C1(=O)C(C([H])([H])[H])(C([H])([H])[H])C(=C2[H])C(=C([H])c(c(O[H])c(OC([H])([H])[H])c(C([H])(C([H])([H])[H])C([H])([H])[H])c3[H])c3C2=O)C([H])=C1[H] | |
| TCMBANKIN049833 | 7beta-acetoxy-9-acetylspicataxine | 7β-acetoxy-9-acetylspicataxine | C41H55NO13 | 769.9 g/mol | CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C)CO4)OC(=O)CC(C5=CC=CC=C5)N(C)C)OC(=O)C)C)OC(=O)C)OC(=O)C |
| TCMBANKIN050010 | Taxumairol A | C37H48O14 | 716.8 g/mol | C1(=C(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@]2([H])[C@@]([H])(O[H])[C@]([H])([C@](O[H])(C([H])([H])OC(=O)c3c([H])c([H])c([H])c([H])c3[H])[C@@]([ H])(OC(=O)C([H])([H])[H])C([H])([H])[C@]4([H])OC(=O)C([H])([H])[H])[C@]4(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])[C@]1([H])OC(=O)C([H])([H])[H] | |
| TCMBANKIN050467 | Taxumairol K | C31H40O11 | 588.6 g/mol | [C@@]1([H])(O[H])[C@]([H])(OC(=O)c2c([H])c([H])c([H])c([H])c2[H])[C@](C([H])([H])[H])([C@]([H])(O[H])C([H])([H])[C@@]([H])(OC3([H])[H])[C@@]34OC(=O)C([H])([H])[H])[C@@]4([H])[C@@]([H])(OC(C([H])([H])[ H])=O)[C@@]5(C(C([H])([H])[H])(O[H])C([H])([H])[H])C1=C(C([H])([H])[H])[C@@]([H])(O[H])C5([H])[H] | |
| TCMBANKIN059360 | 5α-cyprinol | C27H48O5 | CC(CCCC(CO)CO)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | ||
| TCMBANKIN059772 | 19-hydroxybaccatin iii | C31H38O12 | 602.6 g/mol | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)CO)OC(=O)C | |
| TCMBANKIN059789 | 1beta-acetoxy-baccatin i | C32H44O14 | CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)OC(=O)C)OC(=O)C)CO4)O)OC(=O)C)C)OC(=O)C)OC(=O)C | ||
| TCMBANKIN061695 | Majudin | Spectrum2_000534; 5-19-06-00004 (Beilstein Handbook Reference); 4-methoxyfuro[3,2-g]chromen-7-one; Spectrum3_000663; KBio3_001545; CCRIS 4348; KBioGR_002055; 4-methoxy-7-furo[3,2-g]chromenone; DivK1c_000529; NCGC00091582-01; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; KBio2_001274; TNP00299; NINDS_000529; Bergapten; Spectrum5_000155; EINECS 207-604-5; KBio1_000529; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; KBioSS_001274; ACon0_000984; AIDS031096; 4-methoxy-7H-furo[3,2-g]chromen-7-one; HSDB 3466; 5-Methoxypsoralen; Spectrum_000794; KBio2_003842; BSPBio_002325; MEGxp0_000990; 65320_FLUKA; BRN 0019560; 5-Mop; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; NCGC00091582-02; Bergaptene; 5-Methoxy psoralen; NCI60_042121; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; 4-Methoxy-furo[3,2-g]chromen-7-one; IDI1_000529; Bergapten(e); BAS 00674110; ACon1_001979; SPBio_000547; 5-Methoxypsoralen with ultraviolet A therapy; BERGAPTAN; Psoraderm; SDCCGMLS-0066492.P001; NSC95437; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; ZINC00057731; InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; C01557; Heraclin; NCGC00091582-03; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 275727_ALDRICH; Spectrum4_001478; SPECTRUM300546; O-Methylbergaptol; 5-Methoxyfuranocoumarin; NSC 95437; NCGC00017357-01; AIDS-031096; 484-20-8; Oprea1_562364; 5-methoxypsoralen; bergapten;5-19-06-00004 (Beilstein Handbook Reference); AB00052148_06; V0122; DivK1c_000529; NCGC00259906-01; KBio2_001274; EINECS 207-604-5; Geralen; SR-05000002173; KBio1_000529; KBioSS_001274; Majudin; 4-Methoxy-7H-furo[3,2-g]chromen-7-one #; 4-Methoxy-7H-furo[3,2-g]chromen-7-one; HMS501K11; 5-Methoxypsoralen, 99%; SMR000112435; NCGC00017357-03; NCGC00017357-07; CAS-484-20-8; B2840; AK134854; KS-00000GSD; TR-017690; Bergapten(e); NCGC00017357-04; BAS 00674110; CC-24574; C-11626; BERGAPTAN; Psoraderm; D07521; SDCCGMLS-0066492.P001; BRD-K12968785-001-03-4; MLS002207272; 5-Methoxypsoralen (Bergapten); InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; Bergaptene (DCF); 5-methoxy-psoralen; Pentaderm (TN); SPECTRUM300546; HY-N0370; ANW-42611; 5-Methoxypsoralen (obsol.); 5-Methoxy psoralen; KBioGR_002055; Oprea1_562364; Tox21_303255; NCGC00178705-02; Q-100536; Spectrum3_000663; BRD-K12968785-001-02-6; 4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; NCGC00017357-08; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; ZINC57731; TNP00299; Bergapten; BDBM50067880; Spectrum5_000155; NSC755877; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; AB00052148_07; DS-2970; Spectrum_000794; KBio2_003842; 5-methoxy-2H-furo[3,2-g]chromen-2-one; BRN 0019560; NCGC00178705-01; 5-Mop; UNII-4FVK84C92X; M-9412; NCGC00091582-02; HMS2268M24; CHEBI:18293; CS-2234; 5 methoxypsoralen; 5-methoxypsoralen ; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; NCGC00017357-05; SR-05000002173-5; CCG-39946; 5-Methoxypsoralen with ultraviolet A therapy; DSSTox_CID_5560; NSC95437; CJ-00484; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, .gamma.-lactone; NCGC00017357-02; N1304; AC1Q47BC; NCGC00091582-03; SBI-0051583.P002; 4-Methoxy-7H-furo[3,2-g]benzopyran-7-one; NSC 95437; 5-methoxyfurano[3,2-g]chromen-2-one; bergaptene; 484-20-8; CTK3J2399; s4239; Spectrum2_000534; Pentaderm; 4FVK84C92X; KBio3_001545; HMS3652F19; ST2411501; NINDS_000529; STK333038; MCULE-7768334865; NCGC00017357-06; HSDB 3466; 5-Methoxypsoralen; BSPBio_002325; CB-1199; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; BGEBZHIAGXMEMV-UHFFFAOYSA-N; I14-13388; MFCD00010272; bmse000758; IDI1_000529; AB0019675; DB12216; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 4-Methoxyfuro[3,2-g]benzopyran-7-one; O-Methylbergaptol; 484B208; RTR-017690; NCGC00091582-04; SC-46077; AKOS000276715; SR-05000002173-3; CCRIS 4348; DSSTox_GSID_25560; 4-methoxyfuro[3,2-g]chromen-7-one; ZB002242; DTXSID1025560; NSC-755877; NCGC00091582-01; 5-methoxypsoralene; AX8014410; A827532; AJ-09777; ACon0_000984; Tox21_202357; HMS1923G13; FT-0603416; MEGxp0_000990; AC1L1DHU; MolPort-000-880-879; NSC-95437; 4CN-0945; NCI60_042121; BG01521510; 4-Methoxy-furo[3,2-g]chromen-7-one; NCGC00256998-01; AC-20189; CHEMBL24171; SPBio_000547; ACon1_001979; DSSTox_RID_77830; 7H-Furo[3, 4-methoxy-; SR-05000002173-2; Bergapten, analytical standard; SCHEMBL50066; 4-methoxy-7-furo[3,2-g][1]benzopyranone; Heraclin; C01557; Bio-0829; Spectrum4_001478; LS-1292; D0QR5G; Pharmakon1600-00300546; 5-Methoxyfuranocoumarin; MLS002454380; NCGC00017357-01; AN-9448 | C12H8O4 | 216.19 g/mol | COC1=C2C=CC(=O)OC2=CC3=C1C=CO3 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab